Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
74.89
-0.32 (-0.43%)
May 6, 2024, 12:18 PM EDT - Market open
Dr. Reddy's Laboratories Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$80.00
Upside
+6.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +6.82% | Jan 29, 2024 |
| Barclays | Barclays | Buy Maintains $67 → $70 | Buy | Maintains | $67 → $70 | -6.53% | Jun 1, 2023 |
| Barclays | Barclays | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | -10.54% | Oct 31, 2022 |
| Barclays | Barclays | Buy Maintains $69 → $66 | Buy | Maintains | $69 → $66 | -11.87% | Oct 25, 2022 |
| Barclays | Barclays | Buy Maintains $68 → $69 | Buy | Maintains | $68 → $69 | -7.86% | Sep 12, 2022 |
| Barclays | Barclays | Buy Maintains $70 → $68 | Buy | Maintains | $70 → $68 | -9.20% | Jul 25, 2022 |
| Barclays | Barclays | Buy Maintains $69 → $70 | Buy | Maintains | $69 → $70 | -6.53% | May 24, 2022 |
| Barclays | Barclays | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 1, 2021 |
| Barclays | Barclays | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 2, 2021 |
| CLSA | CLSA | Strong Buy → Buy Downgrades n/a | Strong Buy → Buy | Downgrades | n/a | n/a | Jan 28, 2020 |
| Citigroup | Citigroup | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 9, 2020 |
| Jefferies | Jefferies | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Nov 1, 2017 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Sep 21, 2017 |